Breaking: US FDA experts recommend Pfizer covid vaccine, risks remain positive
|A panel of the US Food and Drug Administration (FDA) experts voted 17-4 while favoring that benefits of taking Pfizer and BioNTech's coronavirus (COVID-19) vaccine outweigh the known risks in adults aged 16 years and older.
While the vote authorizes the vaccine usage for emergency usage, the FDA’s official stamp is still awaited, which is likely imminent, before the doctors start using the key drug.
With this, the US joins the line of the UK, Bahrain and Canada while approving (almost) the use of the famous covid vaccine for the pandemic’s cure. Moderna’s covid vaccine will be the next candidate for the US FDA’s approval, around December 17.
FX implications
Although the news is risk-positive, market players already knew about the same and have priced-in. As a result, AUD/USD remains strong near the highest in 30 months while moving a little on the announcement.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.